About Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
During the past decade, Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
2007-08-01
Completed
1,600
A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
1994-11-01
Completed
400
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
1996-09-01
Completed
1,292
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
1998-10-01
Completed
164
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
1997-06-01
Completed
1,750
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
According to Clinical.Site data, the most researched conditions in "Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique" are
"Retinitis Pigmentosa" (2 trials), "Usher Syndrome Type 2" (2 trials), "Deaf Blind" (1 trials), "Eye Diseases" (1 trials) and "Eye Diseases, Hereditary" (1 trials). Many other conditions were trialed in "Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
Most popular intervention types in "Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "QR-421a" (1 trials), "RNA antisense oligonucleotide for intravitreal injection" (1 trials) and "Sham-procedure (dose cohort 1&2 only)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
The vast majority of trials in "Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique" are
2 trials for "All" genders.
Clinical Trials Status at Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
Currently, there are NaN active trials in "Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".